These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35066183)
1. Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction. Stacy MR; Lin BA; Thorn SL; Lobb DC; Maxfield MW; Novack C; Zellars KN; Freeburg L; Akar JG; Sinusas AJ; Spinale FG Heart Rhythm; 2022 May; 19(5):847-855. PubMed ID: 35066183 [TBL] [Abstract][Full Text] [Related]
2. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051 [TBL] [Abstract][Full Text] [Related]
3. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction. Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551 [TBL] [Abstract][Full Text] [Related]
4. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction. Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528 [TBL] [Abstract][Full Text] [Related]
5. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling. Wang W; Zhang HT; Yang XL J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563 [TBL] [Abstract][Full Text] [Related]
6. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling. Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624 [TBL] [Abstract][Full Text] [Related]
7. Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic Thorn SL; Barlow SC; Feher A; Stacy MR; Doviak H; Jacobs J; Zellars K; Renaud JM; Klein R; deKemp RA; Khakoo AY; Lee T; Spinale FG; Sinusas AJ Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009055. PubMed ID: 31707811 [TBL] [Abstract][Full Text] [Related]
8. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis. Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172 [TBL] [Abstract][Full Text] [Related]